Compliance and Regulatory Advisory Services

This contract involves providing specialized advisory services focused on compliance and regulatory issues related to Medicare Part B regulations. The main objective is to offer expert guidance on the correct interpretation and application of these regulations, specifically in relation to the use of drug compendia when making coverage determinations for anti-cancer therapies. This ensures that coverage decisions are aligned with current regulatory requirements and support appropriate patient care. The contract is categorized as a subcontract under the NAICS code 541611, which covers management and technical consulting services. Issued by the Department of Health and Human Services through the Psc Financial Management and Procurement Portfolio, the opportunity was posted on June 9, 2026, with a submission deadline set for June 23, 2026. While specific location details for performance and points of contact are not provided, the work broadly supports regulatory compliance efforts within the healthcare sector, emphasizing the intersection of healthcare policy and pharmaceutical coverage.